Table 1 Patient characteristics
Group I (n = 60) | Group II (n = 82) | |
|---|---|---|
Median Age (range) | 64 (39–86) | 65 (40–88) |
Male n = 49 | (81.7%) | n = 53 (67.1%) |
Female n = 11 | (18.3%) | n = 27 (32.9%) |
Tumor stage | ||
I | 3.5% | 2.3% |
II | 1.8% | 0 |
IIIA | 15.8% | 15.2% |
IIIB | 26.3% | 16.5% |
IV | 52.6% | 65.8% |
Histological features | ||
Squamous Cell Carcinoma | 53.4% | 40.2% |
Adeno Carcinoma | 17.2% | 26.8% |
Large-Cell Carcinoma | 8.6% | 4.9% |
Oat Cell Carcinoma | 15.5% | 11.0% |
Adenoid-cystic Carcinoma | 0 | 2.4% |
Other | 5.1% | 14.6% |
Pre-Treatment: (more than 100% because of different treatment combinations) | ||
None | 2.6% | 12.9% |
Surgery | 29.4% | 20.0% |
Brachytherapy | 2% | 4.2% |
Ext. Irradiation | 41.2% | 35.6% |
Chemotherapy | 23.7% | 27.1% |
ND-YAG laser | 33.3% | 38.8% |
Stent | 7.9% | 9.9% |
Combinations | 45.2% | 45.5% |
Proximal localization of the irradiation probe | ||
Trachea | 17.9% | 20.8% |
Right main bronchus | 57.1% | 55.8% |
Left main bronchus | 5.4% | 7.8% |
Right distal bronchus | 12.5% | 13.9% |
Left distal bronchus | 7.1% | 2.6% |